Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial

Detalles Bibliográficos
Autores principales: von Tresckow, Julia, Cramer, Paula, Robrecht, Sandra, Langerbeins, Petra, Fink, Anna-Maria, Al-Sawaf, Othman, Fürstenau, Moritz, Illmer, Thomas, Klaproth, Holger, Tausch, Eugen, Ritgen, Matthias, Fischer, Kirsten, Wendtner, Clemens-Martin, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Böttcher, Sebastian, Eichhorst, Barbara F., Hallek, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343250/
https://www.ncbi.nlm.nih.gov/pubmed/35752657
http://dx.doi.org/10.1038/s41375-022-01629-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343250/
https://www.ncbi.nlm.nih.gov/pubmed/35752657
http://dx.doi.org/10.1038/s41375-022-01629-7

Ejemplares similares